Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
New words:
absorption, abstaining, ADME, Allan, Allergy, andin, Anselm, APW, aspect, Australia, Billet, biomarker, bound, broker, Brown, career, Carna, Cassidy, cast, Cerep, choice, clearance, commensurate, Compensationabove, Compensationin, Comstock, convince, correlated, disagree, Duke, encompassin, escrow, excretion, factor, FIFO, flagship, footage, Footnote, fuel, GeneMedicine, GENESEP, GENSEP, Hanover, highlighted, HR, India, Innoveda, Invitrogen, Israel, itsin, IV, Kathryn, kinetic, Korea, lipid, living, Lynch, maker, Malaysia, Manyak, Maryland, MDS, Merrill, metabolism, microelectromechanical, milliliter, momentum, NIAID, NIDA, NIH, NovaScreen, offerin, ofin, onin, opted, optimistic, ordinarily, ourin, panel, Paula, PE, percent, pharma, pharmacological, post, pronouncement, providesin, reallocated, reclassification, remitted, saturation, shortly, show, silico, slightly, South, spectrum, statistical, sublet, Teflon, therapeutic, therapy, toin, tox, toxicology, Tunstall, turnkey, unanticipated, unbilled, unconsolidated, undertaken, unfavorable, unusual, Van, Viewlogic, virtually, Virtusa, vitro, vitroADME, vitroassay, vitroexperimentation, vitroproduct, vitroscreening, vitroTOX, vitrotoxicology, vivo, walkaway, web, withheld, Xenogen, XGEN, yearly, Zoology
Removed:
accession, add, Amgen, amounting, ascribed, assistance, balloon, begin, biopharmaceutical, broaden, CA, calling, canceled, cancellation, circumstance, commercialized, compromised, consistently, contractually, controlled, copy, DC, depressed, diminish, easier, electrophoretic, enter, exchanged, exercised, explored, fill, financed, fulfill, fundamental, generating, genomic, harmed, heating, IMAP, industrial, infringed, interface, Internet, lawful, leveraging, Lilly, loan, lost, manipulate, modest, month, NW, organizational, outsource, pertaining, planning, priority, problem, proportionate, reaching, readout, regular, release, renegotiated, renegotiation, repayment, resale, restructure, satisfied, SE, secured, serial, slowdown, standby, structure, submitted, tap, undesirable, useable, utility, vote, Washington
Filing tables
Filing exhibits
- 10-K Annual report
- 2.5 EX-2.5 - Merger Agreement with Xenogen Corp Dated 2/10/2006
- 10.67 EX-10.67 - Offer Letter Dated 9/7/2005
- 21.1 EX-21.1 - Subsidiaries of the Registrant
- 23.1 EX-23.1 - Consent of Ernst & Young LLP
- 31.1 EX-31.1 - Sec 302 Certification of CEO
- 31.2 EX-31.2 - Sec 302 Certification of CFO
- 32.1 EX-32.1 - Sec 906 Certification of CEO
- 32.2 EX-32.2 - Sec 906 Certification of CFO
Related press release
CALP similar filings
Filing view
External links
EXHIBIT 32.1
CALIPER LIFE SCIENCES, INC.
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Caliper Life Sciences, Inc. (the “Company”) on Form 10-K for the year ended December 31, 2005 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, E. Kevin Hrusovsky, President and Chief Executive Officer of the Company certify, pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge, that:
(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Exchange Act; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
/s/ E. KEVIN HRUSOVSKY | ||
E. Kevin Hrusovsky | ||
President and Chief Executive Officer | ||
Date: March 14, 2006 |